schemaVersion:

Form C: Filer Information

Filer CIK:
0002023016 
Filer CCC:
XXXXXXXX 
Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

Turn Therapeutics Inc. 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

01-06-2015 

Physical Address of Issuer:

Address 1:

250 

Address 2:

N. Westlake Blvd. 

City:

WESTLAKE VILLAGE 

State/Country:

CALIFORNIA  

Mailing Zip/Postal Code:

91362 

Website of Issuer:

https://turntherapeutics.com 

Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Offering Information

Offering Information

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

Turn Therapeutics Inc. 

Signature:

/s/ Bradley Burnam 

Title:

Chief Executive Officer and Chairman, Principal Executive Officer 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Bradley Burnam 

Title:

Chief Executive Officer and Chairman (Principal Executive Officer) 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Zuraiz Chaudhary 

Title:

Chief Financial Officer (Principal Financial and Accounting Officer) 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Andrew Gengos 

Title:

Director 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Dr. Neil Ghodadra 

Title:

Director 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Dr. Kent Kester 

Title:

Director 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Arthur F. Golden 

Title:

Director 

Date:

05-12-2026 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/s/ Martin Dewhurst 

Title:

Director 

Date:

05-12-2026